Benzinga - Thu, 25 Mar 2021 08:31:09 -0400
Benzinga - Tue, 23 Mar 2021 11:47:09 -0400
Benzinga - Thu, 18 Mar 2021 05:09:01 -0400
Benzinga - Wed, 17 Mar 2021 05:12:26 -0400
Benzinga - Tue, 16 Mar 2021 12:25:22 -0400
Benzinga - Tue, 16 Mar 2021 12:06:53 -0400
Benzinga - Tue, 16 Mar 2021 10:52:09 -0400
Benzinga - Tue, 16 Mar 2021 10:36:43 -0400
load more
Can Fite Biofarma Ltd is a clinical-stage biopharmaceutical company. The company is focused on developing orally bioavailable small molecule therapeutic products for the treatment of autoimmune inflammatory indications, oncology and liver diseases as well as sexual dysfunction. Its platform technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention. The company's pipeline drugs are synthetic, specific agonists and allosteric modulators targeting the A3AR. All drugs are orally bioavailable with an excellent safety profile.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-06-01
REV
Q4 2020Est.ActualSurprise
EPS-0.010
REV150.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CANFCan Fite Biofarma-3.6%39.1M

Can Fite Biofarma Company Questions & Answers

Q

How do I buy Can Fite Biofarma (CANF) stock?

A

You can purchase shares of Can Fite Biofarma (AMEX: CANF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Can Fite Biofarma's (CANF) main competitors?

A

There are no as such competitors for Can Fite Biofarma.

Q

What is the target price for Can Fite Biofarma?

A

The latest price target for Can Fite Biofarma (AMEX: CANF) was reported by H.C. Wainwright on 2019-09-24. The analyst firm set a price target for 3.00 expecting CANF to rise to within 12 months (a possible 31.87% upside). 0 analyst firms have reported ratings in the last year.

Q

How much is Can Fite Biofarma (CANF) stock ?

A

The stock price for Can Fite Biofarma (AMEX: CANF) is $2.275 last updated Mon Apr 12 2021 19:59:52 GMT+0000 (Coordinated Universal Time).

Q

When is the next Can Fite Biofarma (CANF) dividend?

A

There are no upcoming dividends for Can Fite Biofarma.

Q

When is Can Fite Biofarma (AMEX:CANF) reporting earnings?

A
Can Fite Biofarma’s Q1 earnings are confirmed after-market from now on June 1, 2021.
Q

When is the upcoming split for CANF?

A

There is no upcoming split for Can Fite Biofarma.